Ph1b in patients with Hem Malignancies

Clinical Trial Grant

Duke Scholars

Principal Investigator Harry Paul Erba Medicine, Hematologic Malignancies and Cellular Therapy

Awarded By

Forty Seven, Inc.

Start Date

February 6, 2020

End Date

April 10, 2024

Awarded By

Forty Seven, Inc.

Start Date

February 6, 2020

End Date

April 10, 2024